260 related articles for article (PubMed ID: 26891013)
1. Association between DβH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
Hui L; Han M; Huang XF; Ye MJ; Zhang X; He JC; Lv MH; Soares JC; Zhang XY
J Clin Psychiatry; 2016 Mar; 77(3):379-85. PubMed ID: 26891013
[TBL] [Abstract][Full Text] [Related]
2. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.
Hui L; Zhang X; Yu YQ; Han M; Huang XF; Chen DC; Wang ZR; Du WL; Kou CG; Yu Q; Kosten TR; Zhang XY
Schizophr Res; 2013 Jul; 147(2-3):236-40. PubMed ID: 23707643
[TBL] [Abstract][Full Text] [Related]
3. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
[TBL] [Abstract][Full Text] [Related]
4. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia.
Hui L; Zhang X; Huang XF; Han M; Fernandez F; Yu Y; Sun S; Li W; Chen DC; Xiu MH; Kosten TR; Zhang XY
J Psychiatr Res; 2012 Jun; 46(6):733-7. PubMed ID: 22445279
[TBL] [Abstract][Full Text] [Related]
5. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
Hui L; Rao WW; Yu Q; Kou C; Wu JQ; He JC; Ye MJ; Liu JH; Xu XJ; Zheng K; Ruan LN; Liu HY; Hu WM; Shao TN; AngRabanes MB; Soares JC; Zhang XY
J Psychiatr Res; 2015 Oct; 69():95-101. PubMed ID: 26343600
[TBL] [Abstract][Full Text] [Related]
6. Association between dopamine beta-hydroxylase polymorphism and attention function in suicide attempters with chronic schizophrenia.
Hui L; Hu WM; Zhu ZH; Gao ST; Han M; Fan Y; Tian Q; Yin XY; Yuan Y; Jiang CX; Yin GZ; Jia QF; Zhang XY
Hum Psychopharmacol; 2020 Nov; 35(6):1-8. PubMed ID: 32896003
[TBL] [Abstract][Full Text] [Related]
7. Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.
Punchaichira TJ; Mukhopadhyay A; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
J Psychopharmacol; 2020 Mar; 34(3):358-369. PubMed ID: 31913053
[TBL] [Abstract][Full Text] [Related]
8. Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.
Zhou N; Yu Q; Li X; Yu Y; Kou C; Li W; Xu H; Luo X; Zuo L; Kosten TR; Zhang XY
Hum Psychopharmacol; 2013 May; 28(3):230-7. PubMed ID: 23559427
[TBL] [Abstract][Full Text] [Related]
9. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers.
Zhang XY; Chen DC; Xiu MH; Hui L; Liu H; Luo X; Zuo L; Zhang H; Kosten TA; Kosten TR
Schizophr Res; 2012 Oct; 141(1):48-53. PubMed ID: 22871345
[TBL] [Abstract][Full Text] [Related]
10. Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.
Hui L; Han M; Huang XF; Ye MJ; Zheng K; He JC; Lv MH; Zhang BH; Soares JC; Zhang XY
J Neural Transm (Vienna); 2015 Jun; 122(6):907-14. PubMed ID: 25336319
[TBL] [Abstract][Full Text] [Related]
11. Associations between the DBH gene, plasma dopamine β-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
Sun Z; Ma Y; Li W; He J; Li J; Yang X; Mao P; Cubells JF; Tang YL
Schizophr Res; 2018 Mar; 193():58-63. PubMed ID: 28647493
[TBL] [Abstract][Full Text] [Related]
12. Genetic marker of norepinephrine synthesis predicts individual differences in post-error slowing: a pilot study.
Colzato LS; de Rover M; van den Wildenberg WP; Nieuwenhuis S
Neuropsychologia; 2013 Nov; 51(13):2600-4. PubMed ID: 23962674
[TBL] [Abstract][Full Text] [Related]
13. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
[TBL] [Abstract][Full Text] [Related]
17. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
[TBL] [Abstract][Full Text] [Related]
18. Association between dopamine beta-hydroxylase 19-bp insertion/deletion polymorphism and major depressive disorder.
Zhou Y; Wang J; He Y; Zhou J; Xi Q; Song X; Ye Y; Ying B
J Mol Neurosci; 2015 Feb; 55(2):367-71. PubMed ID: 24888991
[TBL] [Abstract][Full Text] [Related]
19. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia.
Cubells JF; Kranzler HR; McCance-Katz E; Anderson GM; Malison RT; Price LH; Gelernter J
Mol Psychiatry; 2000 Jan; 5(1):56-63. PubMed ID: 10673769
[TBL] [Abstract][Full Text] [Related]
20. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
